Table 3.

Number and percentage of patients with a positive score in the DAI-10 by treatment group

		OLZ	RIS	HAL
		N = 2128	N = 417	N = 112
Baseline	N	960	196	36
	%	53,1	56,6	42,4*
3 months	N	1458	259	58
	%	82,3**	76,4	68,2
6 months	N	1423	252	55
	%	88,1+	78++	67,9

^*p = 0,01 vs RIS; ^**p ≤ 0,011 vs RIS and HAL; +p = 0,001 vs RIS and HAL; ++p = 0,05 vs HAL